Abcellera Biologics Inc.
Clinical trials sponsored by Abcellera Biologics Inc., explained in plain language.
-
New shot aims to cool menopause hot flashes
Symptom relief Recruiting nowThis early-stage study tests a new drug called ABCL635 in healthy people and in postmenopausal women with moderate-to-severe hot flashes. The goal is to see if it is safe and whether it can reduce the number and severity of hot flashes. About 136 participants will receive the dru…
Phase: PHASE1, PHASE2 • Sponsor: AbCellera Biologics Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
New drug ABCL575 put to the test in healthy humans for first time
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called ABCL575 for the first time in people. It involves 40 healthy adults who will receive either a single dose of ABCL575 or a placebo. The main goal is to check if the drug is safe and how the body handles it. No treatment benefit i…
Phase: PHASE1 • Sponsor: AbCellera Biologics Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC